Clearside Biomedi (CLSD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLSD | BMY | AMGN | GILD | REGN |
| Company | Clearside Biomedi | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.4400 | 49.00 | 270.63 | 66.58 | 906.90 |
| High | 1.4500 | 49.05 | 274.86 | 67.19 | 915.70 |
| Low | 1.2900 | 48.55 | 269.65 | 66.37 | 904.41 |
| Last | 1.3400 | 48.86 | 273.01 | 67.08 | 906.54 |
| Change | -0.0300 | -0.13 | -0.53 | +0.05 | -0.78 |
| % Change | -2.19% | -0.27% | -0.19% | +0.07% | -0.09% |
| Volume | 201,048 | 16,031,257 | 2,457,847 | 8,260,006 | 369,600 |
| 20-Day Average Volume | 312,106 | 11,093,288 | 2,113,408 | 6,332,794 | 435,412 |
| Previous Close | 1.3700 | 48.99 | 273.54 | 67.03 | 907.32 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3530 | 50.37 | 271.58 | 69.06 | 926.42 |
| 20-Day Raw Stochastic | 36.36% | 19.10% | 46.26% | 12.61% | 21.62% |
| 20-Day Relative Strength | 47.50% | 41.43% | 48.73% | 32.46% | 40.51% |
| Weighted Alpha | +17.83 | -25.88 | +11.47 | -21.06 | +14.31 |
| Today's Opinion | 24% Buy | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 40% Buy | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 24% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.35% since 04/17/24 | +2.27% since 04/17/24 | +3.60% since 04/17/24 | -0.04% since 04/17/24 | +0.88% since 04/17/24 |
| Low | 1.2400 on 04/18/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 891.46 on 04/19/24 |
| High | 1.4800 on 04/23/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.68 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | -21.64% since 03/22/24 | -5.79% since 03/22/24 | -0.94% since 03/22/24 | -7.86% since 03/22/24 | -6.01% since 03/22/24 |
| Low | 1.1000 on 04/17/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 1.7800 on 03/25/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | +8.94% since 01/24/24 | -2.62% since 01/24/24 | -10.45% since 01/24/24 | -15.87% since 01/24/24 | -4.13% since 01/24/24 |
| Low | 1.1000 on 04/17/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 2.1200 on 03/12/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +78.67% since 10/24/23 | -12.82% since 10/24/23 | -0.92% since 10/24/23 | -14.39% since 10/24/23 | +13.03% since 10/24/23 |
| Low | 0.6501 on 10/26/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 2.1200 on 03/12/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 102,368 | 99,290,928 | 146,720,288 | 83,457,512 | 99,589,264 |
| Shares Outstanding, K | 74,721 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 8,230,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -32,490,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 6,340,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -4,830,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 2.29 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 03/12/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/09/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.55 | 14.58 | 9.96 | 23.95 |